Therapeutics Corp United serves as Executive at TransMedics Group, Inc., where they oversee executive responsibilities. Since joining the company, Therapeutics Corp United has executed 1 insider transactions totaling $9.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 9, 2019 involved selling 500,000 shares valued at $9.4M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 9, 2019 | TMDX | $9.4M | Sale | 500,000 | $18.75 | Discretionary |
Therapeutics Corp United currently holds 2,053,240 shares of TransMedics Group, Inc. (TMDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Therapeutics Corp United has been a net seller of TMDX stock. They have purchased $0 and sold $9.4M worth of shares.
Therapeutics Corp United's most recent insider trade was on Dec 9, 2019, when they sold 500,000 shares at $18.75 per share.
Get notified when new Form 4 filings are submitted